We are live on ! Find out more
OGEN icon

Oragenics
OGEN

13 hedge funds and large institutions have $3.15M invested in Oragenics in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

2% more capital invested

Capital invested by funds: $3.1M → $3.15M (+$53K)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less ownership

Funds ownership: 0.01% → 0.01% (-0%)

13% less funds holding

Funds holding: 15 → 13 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.29%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
3
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$392K
2
Barclays
Barclays
United Kingdom
+$46.8K
3
UBS Group
UBS Group
Switzerland
+$17.5K
4
Northern Trust
Northern Trust
Illinois
+$15K
5
Victory Capital Management
Victory Capital Management
Texas
+$3.34K

Top Sellers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
-$345K
2
SM
Sabby Management
Florida
-$297K
3
Renaissance Technologies
Renaissance Technologies
New York
-$26K
4
VF
Virtu Financial
New York
-$18.4K
5
TSS
Two Sigma Securities
New York
-$18K
Name Holding Trade Value Shares
Change 		Change in
Stake
TS
1
Third Security
Virginia
$836K – – –
HCS
2
Harvest Capital Strategies
California
$720K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$554K +$392K +469 +464%
BlackRock
4
BlackRock
New York
$381K – – –
SM
5
Sabby Management
Florida
$334K -$297K -356 -51%
Barclays
6
Barclays
United Kingdom
$162K +$46.8K +56 +50%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$84K – – –
Northern Trust
8
Northern Trust
Illinois
$24K +$15K +18 +257%
UBS Group
9
UBS Group
Switzerland
$20K +$17.5K +21 New
VF
10
Virtu Financial
New York
$19K -$18.4K -22 -52%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$11K – – –
Victory Capital Management
12
Victory Capital Management
Texas
$4K +$3.34K +4 New
HWM
13
Holloway Wealth Management
Florida
$1K – – –
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$1K +$835 +1 New
CH
15
CVI Holdings
Delaware
– -$345K -391 Closed
Renaissance Technologies
16
Renaissance Technologies
New York
– -$26K -30 Closed
TSS
17
Two Sigma Securities
New York
– -$18K -20 Closed
Deutsche Bank
18
Deutsche Bank
Germany
– -$9K -11 Closed
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
– -$9K -10 Closed

OGEN Hedge Fund Activity: Q3 2019 in Review

13 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q3 2019, worth a combined $3.15M — up 1.7% from $3.1M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of OGEN and 3 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was Vanguard Group, adding an estimated $392K. The largest seller was CVI Holdings, exiting entirely with an estimated $345K sold.

  • 13 institutional investors held Oragenics (OGEN) as of Q3 2019, down from 15 in Q2 2019.
  • Funds reported $3.15M of Oragenics stock for Q3 2019, up 1.7% quarter-over-quarter.
  • 3 funds opened new Oragenics positions in Q3 2019 and 5 closed out, a net change of -2 holders.
  • The largest Oragenics buyer in Q3 2019 was Vanguard Group, an estimated $392K added.
  • The largest Oragenics seller in Q3 2019 was CVI Holdings, an estimated $345K sold.

Based on aggregated 13F filings for Q3 2019.